KIMBERLY BERENBAUM: Open Payments
NPI 1760101182 · PHILADELPHIA, PA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,317 in 25 payments from 7 companies in 2025. Trend: 2023 $746 · 2024 $879 · 2025 $1,317
Food & beverage: $1,233Education: $84
| Company | Payments | Amount |
|---|---|---|
| Janssen Biotech, Inc. | 5 | $614 |
| ABBVIE INC. | 12 | $194 |
| Aimmune Therapeutics, Inc. | 2 | $139 |
| GlaxoSmithKline, LLC. | 1 | $118 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $99 |
| Intercept Pharmaceuticals, Inc. | 1 | $97 |
| PFIZER INC. | 3 | $58 |
Products named: TREMFYA, ZENPEP, AREXVY, OCALIVA, VELSIPITY, RINVOQ, CREON, LINZESS.
Industry payments across PA — which companies pay providers there.
